Allarity Acquisition Corp. is a blank check company targeting life sciences and healthcare, filing for an IPO with Maxim Group LLC as underwriter.

No target business identified yet. They’re hunting for a merger or acquisition without any ongoing operations of their own. Key risk: after a deal closes, shareholders are tied to a single business with no diversification and limited ability to vet the target’s management team. Proceeds from this SPAC IPO will fund the search and eventual business combination, though no specific target or deal terms are set. Bottom line: another healthcare-focused SPAC in a selective market where post-merger performance remains weak. Sponsor and deal quality will matter more than the blank check structure itself.

No target business identified yet. They’re hunting for a merger or acquisition without any ongoing operations of their own.